Ignite Creation Date:
2024-05-05 @ 10:01 PM
Last Modification Date:
2024-10-26 @ 10:13 AM
Study NCT ID:
NCT01018069
Status:
TERMINATED
Last Update Posted:
2011-07-13
First Post:
2009-11-19
Brief Title:
AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen
Sponsor:
Aegera Therapeutics
Organization:
Aegera Therapeutics
Organization Data
Organization:
Aegera Therapeutics
Class:
INDUSTRY
Study ID:
AEG35156-206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Aegera Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jacques Jolivet
Old Organization:
Aegera Therapeutics Inc